YmAbs Therapeutics, Inc. (YMAB) Reports Q3 Loss, Misses Revenue Estimates

Published on November 4, 2021

YmAbs Therapeutics, Inc. (YMAB) delivered earnings and revenue surprises of -10.00% and -15.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for...

Continue reading on website
Other news

Air Lease (AL) Q3 Earnings and Revenues Top Estimates

November 4, 2021
Air Lease (AL) delivered earnings and revenue surprises of 16.00% and 5.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the...

Progyny (PGNY) Q3 Earnings Beat Estimates

November 4, 2021
Progyny (PGNY) delivered earnings and revenue surprises of 142.86% and -2.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?